Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Polymerase chain reaction market to increase at a CAGR of 13%

Polymerase chain reaction market to increase at a CAGR of 13%


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-10-16 17:58:03 - Polymerase chain reaction market to increase at a CAGR of 13%

The polymerase chain reaction (PCR) market is set to continue bucking the economic trend by growing at a compound annual growth rate (CAGR) of 13% through 2015, with global markets expected to exceed $27 billion.To put this into some kind of perspective, this is almost three times greater than the global markets for microarray, flow cytometry and mass spectrometry put together.PCR is a biochemical technology in molecular biology to amplify a single or a few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence.As a technique, PCR offers considerable practical benefits over many proteomics methods, and advances in computing and software continue to accelerate the development of

 

 

new applications and the volumes of biological information PCR methods can generate.Applications for PCR are almost limitless and include sequencing, genetic fingerprinting, cloning, disease research, diagnostics, drug discovery, biomarkers, forensics, viral infections and many more. Such is the enormous power of this technique that some observers have made reference to two epochs in the life science field - "Before PCR" and "After PCR".From the early methods of the 1980s, PCR has taken off and today more than 50 techniques are in use. These are dominated by qPCR, RT-PCR, Hot Start, Multiplex and Taqman techniques. Going forward, these will see continued growth, as will other methods such as Long PCR, Nested PCR, Allele and Methylation-Specific PCR (MSP).PCR is undoubtedly one of the most (if not the most) dynamic technology areas in the life science field today. But while its capabilities appear almost limitless, there are many important challenges to overcome, not least in making it accessible to all.For more information on the polymerase chain reaction market, see the latest research: Polymerase Chain Reaction MarketFollow us on Twitter @CandMResearch

Click for news details: www.companiesandmarkets.com/News/Healthcare-and-Medical/Polymera ..

Browse all Healthcare and Medical C&M News www.companiesandmarkets.com/News/Healthcare-and-Medical/?aCode=f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser